Premphase (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Premphase drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
NON-PROPRIETARY NAME: | conjugated estrogens and medroxyprogesterone acetate |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-03-01 |
END MARKETING DATE: | 0000-00-00 |
Premphase HUMAN PRESCRIPTION DRUG Details:
Item Description | Premphase from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2012-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0046-2575_d2200527-e2ea-45d3-9b7d-3a1c17db5f3e |
PRODUCT NDC: | 0046-2575 |
APPLICATION NUMBER: | NDA020527 |